Arnaud Michel Didierlaurent

Title: Arnaud Michel Didierlaurent: Innovator in Immunogenic Composition

Introduction

Arnaud Michel Didierlaurent is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunology, particularly in the development of methods for inducing immune responses. With a total of 2 patents, his work has the potential to impact vaccine development and therapeutic strategies.

Latest Patents

Didierlaurent's latest patents focus on innovative methods for inducing an immune response. One of his patents describes methods comprising at least two administrations of an adjuvanted immunogenic composition, where the second administration contains reduced amounts of antigen and adjuvant. Another patent outlines methods and uses for inducing an immune response that involve administering a lower dose in the second administration compared to the first, with the possibility of the second administration being unadjuvanted.

Career Highlights

Arnaud Michel Didierlaurent is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. His work at this organization has allowed him to explore and develop advanced immunological techniques that could enhance vaccine efficacy.

Collaborations

Didierlaurent has collaborated with esteemed colleagues such as Robbert Gerrit Van Der Most and William Ripley Ballou, Jr. These collaborations have likely contributed to the depth and breadth of his research in immunology.

Conclusion

Arnaud Michel Didierlaurent stands out as an influential inventor in the field of immunology, with his innovative patents paving the way for advancements in immune response methodologies. His contributions are vital for the future of vaccine development and therapeutic interventions.